Latest Period
Q1 2026
Security Snapshot
PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) Institutional Ownership
CUSIP: 69353Y103
13F Institutional Holders and Ownership History from Q3 2020 to Q1 2026
Institutions Reporting
69
Shares (Excl. Options)
36,961,561
Price
$1.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.00001 par value per share
- Symbol
- PMVP on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 36,961,561
- Total 13F value
- $45,836,687
- Portfolio coverage rank
- 0%
- Share change
- -585,428
- Value change
- -$782,809
- Number of holders
- 69
- Shares outstanding
- 53,625,367
- SEC-reported price per share
- $1.44
- Insider filing price
- $1.44
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share is tracked under CUSIP 69353Y103.
- 69 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 62 to 69 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $46,777,977 to $45,836,687.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 69 institutions filings for Q1 2026.
Security key
69353Y103
Latest holder period
Q1 2026
13F holders
69
13D/G owners
5
CIK / CUSIP context first
Open Q1 2026 holders
PMVP full holder history
PMV Pharmaceuticals, Inc. SEC filings
PMV Pharmaceuticals, Inc. company facts
PMV Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 69353Y103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
PMVP
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 9.9% | +60% | $6,615,000 | +$2,527,616 | 5,292,000 | +62% | BML Investment Partners, L.P. | 31 Dec 2025 |
| TANG CAPITAL MANAGEMENT LLC | 8.9% | $6,702,907 | 4,720,357 | TANG CAPITAL MANAGEMENT, LLC | 16 Sep 2025 | |||
| ArrowMark Colorado Holdings LLC | 5.8% | $3,862,616 | 3,090,093 | ArrowMark Colorado Holdings, LLC | 31 Dec 2025 | |||
| Sio Capital Management, LLC | 5.8% | +16% | $3,845,725 | +$550,040 | 3,076,580 | +17% | Sio Capital Management, LLC | 31 Mar 2026 |
| Euclidean Capital LLC | 4.9% | $3,284,554 | 2,627,643 | Euclidean Capital LLC | 31 Mar 2026 |
As of 31 Mar 2026, 69 institutional investors reported holding 36,961,561 shares of PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP). This represents 69% of the company’s total 53,625,367 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
65%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 9.9% | 5,320,000 | +0.53% | 4.2% | $6,596,800 |
| TANG CAPITAL MANAGEMENT LLC | 7.9% | 4,245,085 | -14% | 0.27% | $5,263,905 |
| Sio Capital Management, LLC | 5.7% | 3,076,580 | +17% | 0.55% | $3,814,959 |
| ArrowMark Colorado Holdings LLC | 5.4% | 2,872,764 | -7% | 0.09% | $3,562,227 |
| Euclidean Capital LLC | 4.9% | 2,627,643 | 0% | 0.83% | $3,258,277 |
| Eversept Partners, LP | 4.4% | 2,348,360 | 0.19% | $2,911,966 | |
| ACADIAN ASSET MANAGEMENT LLC | 4.1% | 2,215,894 | +9.9% | 0% | $2,747,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 1,974,906 | 0% | 0% | $2,448,883 |
| TWO SIGMA INVESTMENTS, LP | 3.5% | 1,884,530 | +167% | 0% | $2,336,817 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.5% | 1,860,000 | 0% | $2,306,400 | |
| BlackRock, Inc. | 1.6% | 874,374 | -20% | 0% | $1,084,223 |
| MORGAN STANLEY | 1.6% | 864,311 | +774% | 0% | $1,071,745 |
| Stonepine Capital Management, LLC | 1.3% | 708,102 | -38% | 0.77% | $878,046 |
| Longaeva Partners L.P. | 1% | 552,027 | 0.03% | $684,513 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.92% | 495,922 | +11% | 0% | $615,455 |
| Aldebaran Capital, LLC | 0.88% | 473,362 | -0.97% | 0.45% | $586,969 |
| MARSHALL WACE, LLP | 0.81% | 434,093 | -6.7% | 0% | $538,276 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.8% | 428,853 | 0% | 0.01% | $531,778 |
| Assenagon Asset Management S.A. | 0.67% | 360,786 | +157% | 0% | $447,375 |
| Walleye Capital LLC | 0.63% | 335,694 | 0% | 0% | $416,261 |
| VANGUARD FIDUCIARY TRUST CO | 0.56% | 298,126 | 0% | 0% | $369,676 |
| BANK OF AMERICA CORP /DE/ | 0.45% | 240,531 | +0.16% | 0% | $298,258 |
| ADAR1 Capital Management, LLC | 0.43% | 231,008 | +129% | 0.02% | $286,450 |
| STATE STREET CORP | 0.34% | 183,178 | 0% | 0% | $227,141 |
| Verdad Advisers, LP | 0.34% | 180,161 | 0.25% | $223,400 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q1 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 36,961,561 | $45,836,687 | -$782,809 | $1.24 | 69 |
| 2025 Q4 | 37,422,687 | $46,777,977 | -$174,801 | $1.25 | 62 |
| 2025 Q3 | 37,492,718 | $52,488,395 | +$4,772,987 | $1.40 | 63 |
| 2025 Q2 | 34,680,709 | $36,758,763 | -$2,911,770 | $1.06 | 52 |
| 2025 Q1 | 37,320,031 | $40,676,123 | -$2,281,115 | $1.09 | 54 |
| 2024 Q4 | 38,959,310 | $58,833,270 | -$767,790 | $1.51 | 70 |
| 2024 Q3 | 39,023,873 | $58,153,846 | -$2,416,795 | $1.49 | 73 |
| 2024 Q2 | 40,492,185 | $65,594,864 | -$3,771,661 | $1.62 | 91 |
| 2024 Q1 | 42,725,320 | $72,627,924 | -$11,853,919 | $1.70 | 96 |
| 2023 Q4 | 46,465,983 | $144,025,863 | -$52,160,467 | $3.10 | 97 |
| 2023 Q3 | 54,236,025 | $333,006,052 | +$15,386,619 | $6.14 | 103 |
| 2023 Q2 | 51,696,984 | $323,689,509 | +$3,281,155 | $6.26 | 104 |
| 2023 Q1 | 51,513,177 | $245,718,220 | -$16,150,590 | $4.77 | 111 |
| 2022 Q4 | 54,555,170 | $474,625,571 | -$38,255,414 | $8.70 | 113 |
| 2022 Q3 | 58,187,852 | $692,436,457 | -$36,596,424 | $11.90 | 116 |
| 2022 Q2 | 61,123,657 | $870,921,498 | +$53,476,878 | $14.25 | 105 |
| 2022 Q1 | 55,249,345 | $1,150,065,944 | +$162,099,243 | $20.82 | 98 |
| 2021 Q4 | 47,470,437 | $1,096,597,184 | +$15,190,740 | $23.10 | 102 |
| 2021 Q3 | 43,990,444 | $1,310,907,931 | +$46,789,977 | $29.80 | 91 |
| 2021 Q2 | 42,241,228 | $1,442,956,792 | +$80,038,413 | $34.16 | 83 |
| 2021 Q1 | 39,915,363 | $1,312,819,295 | +$51,865,975 | $32.89 | 81 |
| 2020 Q4 | 38,212,089 | $2,335,342,669 | +$185,049,476 | $61.51 | 72 |
| 2020 Q3 | 31,212,908 | $1,098,804,001 | +$1,098,804,001 | $35.50 | 51 |